Navigation Links
New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
Date:9/1/2009

still occurring.[3]

Multifactorial intensive therapy (including statins) is insufficient to prevent the development or progression of microvascular disease (retinopathy, nephropathy, neuropathy) in up to 50 percent of patients with type 2 diabetes.[4]

Atherogenic Dyslipidemia and Residual Vascular Risk

Atherogenic dyslipidemia is characterized by elevated TG and low levels of HDL-C.

In the past three decades in the U.S., while the prevalence of abnormal levels of LDL-C has decreased, the prevalence of combined abnormal TG (greater than or equal to 150 mg/dL) and HDL-C (<40 mg/dL) has doubled and the prevalence of elevated TG (greater than or equal to 150 mg/dL) has increased five-fold.[5] Elevated TG (>150 mg/dL) is also common, affecting about 50 percent of adults with prior CVD.[6]

Atherogenic dyslipidemia contributes to the increased risk of macrovascular events such as myocardial infarction and stroke, and may be implicated in microvascular complications such as diabetic eye, kidney and lower limb disease.[7]

    - Among patients achieving LDL-C <70 mg/dL with a statin, CVD risk is
      almost 60 percent greater for patients with TG >200 mg/dL[8]

    - In patients achieving LDL-C <70 mg/dL with a statin, CV risk was higher
      in patients with a low HDL-C (HDL-C <37 mg/dL vs. those with a
      HDL-C >55 mg/dL)[9]

The mission of R3i

To reduce the significant residual risk of macrovascular events and microvascular complications which persists in most patients despite current standards of care including achievement of low density lipoprotein goal and intensive control of blood pressure and blood glucose.

    R3i board of trustees

    Professor Jean-Charles Fruchart, President   Institut Pasteur de
                                                 Lille Universite, Lille2,
            
'/>"/>
SOURCE Residual Risk Reduction Initiative Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dental Implant Market Insights Webinar
2. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
3. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
4. New insights into the fate of anti-parasitics in manure and manured soils
5. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
6. PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference
7. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
8. New insights into cellular reprogramming revealed by genomic analysis
9. Peripheral Vascular Device Market Insights Webinar
10. Microsurgery on the brain of the fruit fly leads to new insights into irreparable nerve injuries
11. Protein Research Marketing Insights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 29, 2015 A ... acquiring, rapidly developing and commercialising innovative medicines to ... Highly experienced management team; blue chip ...   Mereo BioPharma Group Ltd ("Mereo"), a recently-formed ... ( c. £76.5m), gross, from blue chip institutional investors ...
(Date:7/28/2015)... 28, 2015  PDL BioPharma, Inc. (PDL, or the ... Company will release its second quarter 2015 financial results ... August 5, 2015, after market close. PDL,s management will ... 4:30 p.m. Eastern Time to discuss the financial results. ... available via the webcast link on the PDL website. ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... more than EUR 1.022 billion in 2013; while production volume reached close to ... leading producing country with a share of 75.5% of the region’s total aluminium ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... VetStem ... a live stem cell credentialing course to local area veterinarians. , The tour and ... approved CE units at no charge) at VetStem’s Poway facility. Staff members are welcome ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2
... Toronto Stock Exchange Symbol: MS, EDMONTON, Nov. 5 /PRNewswire-FirstCall/ ... treatment of multiple sclerosis (MS), today,announced that Mr. Kevin Giese, ... Annual Healthcare Conference in New York., WHEN: ... WHERE: New York Palace Hotel, New ...
... Therapeutics Inc., a privately,held biopharmaceutical company, announced ... Dr. John Dietrich have joined its Board ... commented: "It is a great,pleasure to welcome ... Board,where they will enhance our capabilities in ...
... 5 Dendreon Corporation (Nasdaq:,DNDN) today announced that management will ... & Renshaw 10th Annual Healthcare Conference New York Palace ... Lazard Capital Markets 5th Annual Healthcare Conference The ... 8:55 a.m. ET, The presentations will be audio ...
Cached Biology Technology:BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference 2Trillium Strengthens its Board of Directors 2
(Date:7/7/2015)... July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... growing mobile commerce market announces a revised version of one of ... commercial will air on CNBC in New York ... and San Francisco metro areas.    ... on Wocket,s ability to replace all the cards in your wallet ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... now, the scientific community had thought that whistles were ... unaware of the importance and use of burst-pulsed sounds. ... in Sardinia (Italy) have now shown that these sounds ... their behaviour. , "Burst-pulsed sounds are used in the ...
... Patients in the early to moderate stages ... slowed or even reversed by switching to a ... In a previous study [ http://www.temple.edu/newsroom/2009_2010/12/stories/alzheimers.htm ], ... of pharmacology in Temple,s School of Medicine, demonstrated ...
... at Oregon State University have demonstrated for the first ... trees can be changed through "cisgenics" a type ... plant breeding. Cisgenics uses genes from closely related ... to regulate it similarly to conventional breeding, experts say, ...
Cached Biology News:Dolphins use diplomacy in their communication 2Healthy diet could slow or reverse early effects of Alzheimer's disease 2Success with 'cisgenics' in forestry offers new tools for biotechnology 2Success with 'cisgenics' in forestry offers new tools for biotechnology 3
Recombinant Rat Leptin, Ultra Pure...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: